TRIVAGIZOLE 3 Drug Patent Profile
Which patents cover Trivagizole 3, and what generic alternatives are available?
Trivagizole 3 is a drug marketed by Sun Pharma Canada and is included in one NDA.
The generic ingredient in TRIVAGIZOLE 3 is clotrimazole. There is one drug master file entry for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the clotrimazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Trivagizole 3
A generic version of TRIVAGIZOLE 3 was approved as clotrimazole by ENCUBE on July 16th, 1993.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TRIVAGIZOLE 3?
- What are the global sales for TRIVAGIZOLE 3?
- What is Average Wholesale Price for TRIVAGIZOLE 3?
Summary for TRIVAGIZOLE 3
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 108 |
| Patent Applications: | 4,736 |
| DailyMed Link: | TRIVAGIZOLE 3 at DailyMed |
Pharmacology for TRIVAGIZOLE 3
| Drug Class | Azole Antifungal |
US Patents and Regulatory Information for TRIVAGIZOLE 3
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharma Canada | TRIVAGIZOLE 3 | clotrimazole | CREAM;VAGINAL | 021143-001 | Apr 12, 2000 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
